pricethispeptide.

Product identity before price

Tesamorelin prices.

Approved EGRIFTA WR and provider-listed preparations, with the product identity and minimum commitment kept separate.

SemaglutideTirzepatideLiraglutideOrforglipronSermorelinNAD+GlutathioneCopper peptidesPT-141TesamorelinVIPOxytocin
3 listed offers3 providers / brandsChecked October 8–9, 2026

Inspect the terms, then compare

Published offers.

3 offers shown

Sorting compares displayed numbers only. Billing units, routes, supply periods and included services can differ. Unpriced records sort last. Care-only prices exclude medication. Featured placements above are separate.

M
MaximusInjection · Provider-listed prescription

Tesamorelin protocol

Provider-listed prescription

The official protocol guide names this medicine. Generic growth-hormone program prices do not establish its selected intensity, formulation or total bill.

Quote requiredProduct-specific price unconfirmedRead the breakdown →
T
TheratechnologiesInjection · FDA-approved medicine

EGRIFTA WR

FDA-approved medicine

Approved for excess abdominal fat in adults with HIV-associated lipodystrophy; not indicated for weight-loss management. No universal cash price established.

Quote requiredInsurance or specialty-pharmacy quoteRead the breakdown →

What this board can tell you.

EGRIFTA WR is approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Its label specifically excludes weight-loss management and says long-term cardiovascular safety has not been established. A provider listing for tesamorelin does not establish that this approved brand is supplied. Compounded preparations do not inherit its approval.

Sources: EGRIFTA WR — prescribing information, FDA — compounding questions and answers

Follow the evidence

Sources & price notes

Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.

  1. EGRIFTA WR — prescribing information ↗

    Label defines the indication, limitations, contraindications and monitoring requirements. EGRIFTA WR is not indicated for weight-loss management.

    Checked October 9, 2026

  2. FDA — compounding questions and answers ↗

    Clinical and regulatory context. A compounded preparation is not FDA-approved.

    Checked October 8, 2026

  3. Maximus — choosing a protocol ↗

    The official help article identifies sermorelin and tesamorelin. Product-specific quotations still require confirmation.

    Checked October 9, 2026

  4. Maximus — growth hormone program ↗

    Program-level prices vary by commitment. Do not assign the generic program price to every medication or intensity.

    Checked October 9, 2026

  5. TRT Nation — peptide menu ↗

    NAD+ $120/month and glutathione $80/month require a 2.5-month minimum. Sermorelin $199.99/month; tesamorelin $233/month with a three-month minimum. Minimum-cost arithmetic is not a verified checkout total.

    Checked October 9, 2026

  6. Theratechnologies — EGRIFTA WR ↗

    Approved tesamorelin brand for excess abdominal fat in adults with HIV-associated lipodystrophy. No universal cash price was established.

    Checked October 9, 2026

  7. THERA patient support ↗

    Insurance and financial-assistance support subject to eligibility. A support program is not a universal medication price.

    Checked October 9, 2026